Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (1762) Financial Statements

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A Financial Overview

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A's market cap is currently NT$2.39B. The company's EPS TTM is NT$-0.93; its P/E ratio is -35.22; and it has a dividend yield of 0.62%. Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Mar 23Dec 21
Income Statement
Total RevenueNT$ 804.88MNT$ 1.35BNT$ 2.09BNT$ 2.12BNT$ 1.93B
Gross ProfitNT$ -8.86MNT$ 394.32MNT$ 757.31MNT$ 961.76MNT$ 949.39M
Operating IncomeNT$ -319.54MNT$ 6.34MNT$ 280.81MNT$ 574.67MNT$ 519.28M
EBITDANT$ -47.60MNT$ 277.66MNT$ 545.93MNT$ 743.72MNT$ 651.27M
Net IncomeNT$ -243.85MNT$ 53.03MNT$ 264.91MNT$ 465.87MNT$ 400.78M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 216.44MNT$ 222.28MNT$ 269.57MNT$ 300.61MNT$ 195.25M
Total AssetsNT$ 4.32BNT$ 4.76BNT$ 5.17BNT$ 4.56BNT$ 4.38B
Total DebtNT$ 805.86MNT$ 858.17MNT$ 1.21BNT$ 604.54MNT$ 753.55M
Net DebtNT$ 589.42MNT$ 635.89MNT$ 939.54MNT$ 303.93MNT$ 558.30M
Total LiabilitiesNT$ 1.23BNT$ 1.41BNT$ 1.82BNT$ 1.37BNT$ 1.49B
Stockholders' EquityNT$ 3.09BNT$ 3.36BNT$ 3.35BNT$ 3.19BNT$ 2.89B
Cash Flow
Free Cash FlowNT$ 80.28MNT$ 362.96MNT$ -517.83MNT$ 357.60MNT$ -186.27M
Operating Cash FlowNT$ 142.61MNT$ 467.65MNT$ -77.50MNT$ 733.78MNT$ 219.18M
Investing Cash FlowNT$ -61.80MNT$ -100.10MNT$ -461.32MNT$ -376.18MNT$ -802.75M
Financing Cash FlowNT$ -86.03MNT$ -415.72MNT$ 496.57MNT$ -253.32MNT$ 630.62M

Currency in TWD

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A Earnings and Revenue History

-1.2B01.2B2.4B-40 %0 %40 %80 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A Liabilities to Assets

02B4B6B15 %30 %45 %60 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A Cash Flow

-1.5B-1B-500M0500M1B201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A Forecast EPS vs Actual EPS

-3-2-10123Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >